DAPAGLIFLOZIN for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,534 adverse event reports in the FDA FAERS database where DAPAGLIFLOZIN was used for Product used for unknown indication.
Most Reported Side Effects for DAPAGLIFLOZIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,775 | 13.0% | 2,774 | 52 |
| Diabetic ketoacidosis | 1,773 | 8.3% | 61 | 1,154 |
| Acute kidney injury | 982 | 4.6% | 67 | 768 |
| Off label use | 891 | 4.2% | 28 | 310 |
| Nausea | 884 | 4.1% | 20 | 363 |
| Dehydration | 860 | 4.0% | 67 | 451 |
| Vomiting | 838 | 3.9% | 27 | 419 |
| Dizziness | 817 | 3.8% | 30 | 293 |
| Ketoacidosis | 803 | 3.8% | 30 | 471 |
| Fatigue | 785 | 3.7% | 8 | 227 |
| Diarrhoea | 769 | 3.6% | 32 | 317 |
| Dyspnoea | 760 | 3.6% | 21 | 328 |
| Malaise | 737 | 3.5% | 30 | 308 |
| Weight decreased | 727 | 3.4% | 23 | 231 |
| Blood glucose increased | 699 | 3.3% | 12 | 247 |
Other Indications for DAPAGLIFLOZIN
Type 2 diabetes mellitus (5,444)
Diabetes mellitus (3,347)
Cardiac failure (1,332)
Chronic kidney disease (585)
Ill-defined disorder (556)
Cardiac failure chronic (498)
Type 1 diabetes mellitus (308)
Blood glucose increased (145)
Blood glucose abnormal (127)
Blood glucose decreased (72)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)